14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of JANX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Janux Therapeutics, Inc. stock price on Friday moving between $59.31 and $65.60
(Updated on May 03, 2024)

Buy or Hold candidate since Feb 20, 2024 Gain 550.40% PDF

The Janux Therapeutics, Inc. stock price gained 3.76% on the last trading day (Friday, 3rd May 2024), rising from $62.43 to $64.78. It has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 10.61% from a day low at $59.31 to a day high of $65.60. The price has risen in 8 of the last 10 days and is up by 33.05% over the past 2 weeks. Volume fell on the last day by -70 thousand shares and in total, 1 million shares were bought and sold for approximately $67.29 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 116.12% during the next 3 months and, with a 90% probability hold a price between $107.34 and $181.41 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

JANX Signals & Forecast

The Janux Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $56.14 and $45.21. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, April 05, 2024, and so far it has risen 84.45%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Janux Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $56.08 and $50.00. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Janux Therapeutics, Inc. finds support just below today's level at $56.08. If this is broken, then the next support from accumulated volume will be at $50.00 and $49.75.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $6.29 between high and low, or 10.61%. For the last week, the stock has had daily average volatility of 13.50%.

Since the Janux Therapeutics, Inc. has been rising for 6 days in a row, the risk over the next couple of days has increased. As we cannot be certain with regards to the size of the reaction, we urge caution.

Our recommended stop-loss: $61.53 (-5.02%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 20 days ago.)

Trading Expectations (JANX) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Janux Therapeutics, Inc. to open at $63.23, and during the day (based on 14 day Average True Range), to move between $60.15 and $69.41, which gives a possible trading interval of +/-$4.63 (+/-7.15%) up or down from last closing price. If Janux Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 14.31% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $56.08, some $8.70 (13.43%) from the current price of $64.78, our system finds the risk reward attractive.

Is Janux Therapeutics, Inc. stock A Buy?

Janux Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Janux Therapeutics, Inc. of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$63.23 ( 2.39%) $64.78

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for JANX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 69.52 7.32 %
R2 67.12 3.61 %
R1 65.63 1.32 %
Current price: 64.78
Support S1 60.83 -6.10 %
S2 59.34 -8.39 %
S3 56.94 -12.10 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 64.78
Support S1 56.08 -13.43%
S2 50.00 -22.82%
S3 49.75 -23.20%

FAQ

What is the symbol for Janux Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Janux Therapeutics, Inc. is JANX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Janux Therapeutics, Inc. Stock?
Janux Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Janux Therapeutics, Inc. Stock?
Janux Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Janux Therapeutics, Inc. Stock.

What's the current price of Janux Therapeutics, Inc. Stock?
As of the end of day on the May 03, 2024, the price of an Janux Therapeutics, Inc. (JANX) share was $64.78.

What is the 52-week high and low for Janux Therapeutics, Inc. Stock?
The 52-week high for Janux Therapeutics, Inc. Stock is $65.60 and the 52-week low is $5.65.

What is the market capitalization of Janux Therapeutics, Inc. Stock?
As of the May 03, 2024, the market capitalization of Janux Therapeutics, Inc. is 3.359B.

When is the next earnings date for Janux Therapeutics, Inc.?
The upcoming earnings date for Janux Therapeutics, Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About Janux Therapeutics, Inc.

Janux Therapeutics. Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. Janux Therapeutics, Inc. is also developing a ... JANX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT